Skip to main content
Premium Trial:

Request an Annual Quote

Armonica Technologies Closes $2M Series B Financing Round

NEW YORK – Sequencing technology company Armonica Technologies said on Monday that it has closed a $2 million Series B financing round.

Hamamatsu Photonics joined as a new investor, as did previous investors Cottonwood Technology Fund, Sun Mountain Capital, and Tramway Venture Partners.

In a statement, Armonica said the funding will be used to support further feasibility demonstrations of its sequencing technology.

Based in Albuquerque, New Mexico, Armonica is developing a solid-state nanopore sequencing device that uses Raman spectroscopy for detection. In April, the firm announced that it identified spectral fingerprints for the four natural DNA bases as well as nine epigenetically modified bases.

In March, the firm announced that it had received a $349,200 Small Business Innovation Research grant from the National Human Genome Research Institute to optimize its nanostructures for single-base sensitivity and spatial resolution.


The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.